Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Tolerability”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT03677960
What this trial is testing

Study of Topical ABI-1968 in Subjects With Precancerous Anal Lesions Resulting From Human Papillomavirus (HPV) Infection

Who this might be right for
HSIL, High-Grade Squamous Intraepithelial LesionsHuman Papilloma Virus InfectionHIV Infection+2 more
Antiva Biosciences 6
Testing effectiveness (Phase 2)Study completedNCT04721223
What this trial is testing

JAB-3068 Activity in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorEsophageal Squamous Cell CarcinomaNon Small Cell Lung Cancer+1 more
Jacobio Pharmaceuticals Co., Ltd. 12
Testing effectiveness (Phase 2)Study completedNCT04140123
What this trial is testing

Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Who this might be right for
Non-Alcoholic Steatohepatitis (NASH)
Guangdong Raynovent Biotech Co., Ltd 37
Testing effectiveness (Phase 2)Study completedNCT02118012
What this trial is testing

Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 24
Testing effectiveness (Phase 2)Looking for participantsNCT06598007
What this trial is testing

Determine the Effect of CT3001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, AdultColorectal CancerPancreatic Ductal Adenocarcinoma
Crossignal Therapeutics, Inc. 78
Testing effectiveness (Phase 2)Study completedNCT01149707
What this trial is testing

Safety, Tolerability, Efficacy Study of PUR 0110 Rectal Enema in Mild-to-Moderate Distal Ulcerative Colitis

Who this might be right for
Left-Sided Ulcerative ColitisProctosigmoiditis
PurGenesis Technologies Inc. 34
Early research (Phase 1)Looking for participantsNCT07423000
What this trial is testing

PVT401 in Healthy Subjects

Who this might be right for
Inflammatory Bowel Disease (IBD)
Parvus Therapeutics, Inc. 36
Early research (Phase 1)Looking for participantsNCT07481357
What this trial is testing

A First-In-Human Phase I/IIa Study to Evaluate DA 3501 in Patients With Advanced Gastric or Gastro-esophageal Junction Adenocarcinoma and Pancreatic Ductal Adenocarcinoma

Who this might be right for
Gastric (Stomach) CancerGastroEsophageal CancerPancreatic Ductal Adenocarcinoma (mPDAC)
Dong-A ST Co., Ltd. 51
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Early research (Phase 1)Study completedNCT01023230
What this trial is testing

Assess DV-601 in Subjects With Chronic Hepatitis B

Who this might be right for
Hepatitis B, Chronic
Dynavax Technologies Corporation 14
Testing effectiveness (Phase 2)Study completedNCT01043185
What this trial is testing

Estimate Effect of 4 Different Doses of AZD3355 on Reflux Episodes, Which Patients With Gastroesophageal Reflux Disease (GERD) May Experience

Who this might be right for
Gastroesophageal Reflux Disease
AstraZeneca 27
Post-approval studies (Phase 4)UnknownNCT00611494
What this trial is testing

Gastrointestinal Tolerability of MMF vs EC-MPS in Maintenance Transplant Patients Treated With Calcineurin Inhibitors

Who this might be right for
Organ Transplantation
University Health Network, Toronto 400
Testing effectiveness (Phase 2)Study completedNCT01441180
What this trial is testing

GS-7977 With Ribavirin for Hepatitis C (SPARE)

Who this might be right for
Hepatitis C
National Institute of Allergy and Infectious Diseases (NIAID) 60
Early research (Phase 1)Ended earlyNCT03144661
What this trial is testing

An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaEsophageal Cancer+3 more
Incyte Corporation 25
Testing effectiveness (Phase 2)Looking for participantsNCT05468359
What this trial is testing

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

Who this might be right for
Refractory Solid TumorHepatocellular CarcinomaMalignant Solid Tumor+3 more
St. Jude Children's Research Hospital 64
Early research (Phase 1)Study completedNCT03493841
What this trial is testing

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Who this might be right for
Multiple SclerosisProgressive Multiple SclerosisSecondary Progressive Multiple Sclerosis+1 more
Rebecca Spain 20
Early research (Phase 1)Ended earlyNCT03685591
What this trial is testing

PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors

Who this might be right for
Breast NeoplasmsProstate NeoplasmsNeoplasms, Squamous Cell+6 more
Pfizer 49
Early research (Phase 1)Study completedNCT01944735
What this trial is testing

Phase 1 Study Assessing the Safety and Tolerability of CTX-4430 in Cystic Fibrosis Patients

Who this might be right for
Cystic Fibrosis
Celtaxsys, Inc. 17
Early research (Phase 1)Study completedNCT00503490
What this trial is testing

Safety, Pharmacokinetic and Pharmacodynamic Study of MP-376 in Patients With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Amgen 40
Testing effectiveness (Phase 2)Looking for participantsNCT07223047
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies

Who this might be right for
Advanced Solid MalignanciesNon-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)+1 more
Bristol-Myers Squibb 252
Next Page